The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metformin use and survival in diabetic patients with renal cell carcinoma (RCC).
Nilay Shah
No relevant relationships to disclose
Farhad Khimani
No relevant relationships to disclose
Brendan F. Curley
No relevant relationships to disclose
Michael David Newton
No relevant relationships to disclose
Thomas F. Hogan
No relevant relationships to disclose
Sijin Wen
No relevant relationships to disclose
Yanqing Hu
No relevant relationships to disclose
Manish Monga
No relevant relationships to disclose